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ABSTRACT  Upon fertilization, the gametes undergo a drastic reprogramming that includes
changes in DNA methylation and histone modifications. Currently, it is not known whether
replacement of the major histones by histone variants is also involved in these processes. Here we
have examined the expression and localization of the histone variant H3.3 in early mouse
embryogenesis. We show that H3.3 is present in the oocyte as a maternal factor. It is then
incorporated preferentially into the male pronucleus before genome activation, pointing towards
an asymmetry in histone composition between the two pronuclei. This is in line with the male
pronucleus bearing transcriptional activation first. The same distribution was observed when we
followed the localisation of a tagged version of H3.3. We detected H3.3 in the nuclei of mouse
embryos in all of the stages analysed, from the zygote to the blastocyst stage, suggesting that the
epigenetic mechanisms in the early embryo not only involve changes in histone modifications but
may also include histone replacement.
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Introduction
The removal and acquisition of new epigenetic marks during
preimplantation development is essential to ensure the totipo-
tency required for sustaining further development. In the zygote,
changes in the epigenetic status of the parental genomes may
also be needed for the activation of zygotic transcription. Covalent
modifications of histones and DNA methylation are considered as
the most important epigenetic marks in preimplantation develop-
ment (Li, 2002, Morgan et al., 2005).
In the early zygote, histones H3 and H4 are synthesized from
maternal mRNA, whereas the synthesis of histones H2A, H2B
and H1, is delayed until the end of the first cell cycle (Wiekowski
et al., 1997). Covalent modifications of histones contribute to the
formation and maintenance of transcriptionally active or inactive
chromatin domains. Acetylation of lysine (K) residues is generally
associated with transcriptional activation whereas methylation of
lysine residues can have opposing outcomes (repression or
activation) depending on the precise methylation site. Apart from
the major core histones, whose synthesis is tightly linked to the S-
phase of the cell cycle, some histones are synthesized from
orphan genes throughout the cell cycle and are incorporated into
the chromatin independently of replication (Kamakaka and Biggins,
2005). These ‘replacement’ histones are also covalently modified
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and can also be used to ‘mark’ the chromatin and hence regulate
gene expression. Moreover, they can elicit different chromatin
conformations upon assembly into the nucleosomes (Gautier et
al., 2004). One interesting variant is H3.3, which can replace
histone H3. The replication-independent deposition of histone
variants allows the turnover of modification marks and hence a
change of the heritable chromatin states. For example, upon gene
activation, H3 carrying the repressive methyl H3K9 mark be-
comes replaced by H3.3 unmethylated at K9. Moreover, preferen-
tial deposition of H3.3 in transcriptionally active regions would
result in perpetuation of epigenetic memory (Ahmad and Henikoff,
2002b, Schwartz and Ahmad, 2005). Although a growing number
of reports support a role for the histone variants in regulating
chromatin activity, their specific functions in vivo are not fully
understood.
 Several recent studies have analysed histone modifications in
early embryos (Adenot et al., 1997, Arney et al., 2002, Lepikhov
and Walter, 2004, Santos et al., 2005, Sarmento et al., 2004).
However, to obtain a better understanding of the reprogramming
taking place in the mammalian embryo, it is also necessary to
define the components of the chromatin present throughout
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preimplantation development. Here, we have characterized the
localization of the replacement histone variant H3.3 in mouse
oocytes and early embryos. The histone variant H3.3 was present
in all the stages examined. In the zygote, it showed an asymmetric
distribution between the male and female pronucleus. We also
observed that the pattern of localization of H3.3 changes from a
punctate to a more disperse nuclear staining after the 2-cell stage.
Results
Here, we were interested in examining the distribution of the
replacement histone variant H3.3 in oocytes and preimplantation
mouse embryos. The characterisation of the H3.3 antibody used
in this study is shown in Figure 1A. Only the specific H3.3 peptide
competes the antibody. Importantly, the H3.3 antibody does not
recognise a recombinant purified H3.2 variant, testifying for the
specificity of the antibody. Using this H3.3 specific antibody we
analysed the distribution of H3.3 in the oocyte. The H3f3a gene,
encoding H3.3, was previously reported to be expressed in the
growing oocyte (Couldrey et al., 1999). H3.3 clearly accumulates
in the germinal vesicle (GV), but it is also detectable in the
cytoplasm (Fig. 1B, left panel). After fertilisation, the maternal
genome resumes meiosis from metaphase II and extrudes the
second polar body containing the second set of haploid chromo-
somes. During this time, which corresponds to the pronuclear
stage PN0 (Adenot et al., 1997), H3.3 is only weakly dispersed in
the cytoplasm with no obvious localisation in either the maternal
or the paternal pronuclei (Fig. 1B, right panel).
The pronuclei are subsequently subject to cycles of
decondensation and migrate towards the centre of the zygote. We
first detect an enrichment of H3.3 in the pronuclei during
decondensation around the PN2 stage. This enrichment is asym-
metric between the two pronuclei: it is evident in the male
pronucleus, but not in the female one. At this stage, a weak
staining of the cytoplasm suggests localisation of H3.3 in the
cytoplasm, probably reflecting translation, storage or association
with chaperone molecules (Fig. 2A). Thus, the maternal genome
is associated with H3.3 in the GV, but H3.3 is then undetectable
in the maternal chromatin during pronuclear formation and its
incorporation starts earlier in the male pronucleus. In PN3-PN4
zygotes the pronuclei increase in size and locate close to each
other in the centre of the cell. At this stage, the enrichment of H3.3
is still slightly brighter in the male pronucleus, but the female
pronucleus also shows accumulation of H3.3 (the signal/size ratio
of the male pronucleus compared to the female one was 1.8 ±
0.17, n=7, as quantified with the Volocity software, Improvision)(Fig.
2A). Before mitosis, the pronuclei become apposed (PN5), at this
stage H3.3 is present in the two pronuclei and a difference in H3.3
accumulation between the male and the female pronucleus is no
longer detected (Fig. 2A). At the 2-cell stage H3.3 is present in the
two nuclei of the two blastomeres (Fig. 2A).
H3.3 can be deposited via a replication-independent pathway
that is triggered upon transcriptional activation (Janicki et al.,
2004, Schwartz and Ahmad, 2005). We therefore wished to know
whether the time when we first saw deposition of H3.3 in the
zygote corresponded to the time when the genome activation
occurs. Thus, we followed the incorporation of BrUTP in the
zygote by immunofluorescence. When examined at 24h phCG
(approximately PN3-PN4 stages), we do not detect BrUTP in
either pronucleus, indicating that the zygote is not yet transcrip-
tionally active at this stage (Fig. 2B). However, when examined at
27h phCG (PN5), we detect BrUTP staining throughout the
nucleoplasm with sites of brighter intensity around the nucleolar-
like bodies in the two pronuclei (Fig. 2B). This is consistent with
the observation that the zygote undergoes transcriptional activa-
tion between 26h and 29h phCG (Aoki et al., 1997, Bouniol et al.,
1995). H3.3 exhibits a characteristic punctate staining throughout
the nucleoplasm at these early stages and in the oocyte, which
persists from the PN3 zygote stage up to the 2-cell stage (Fig. 2C).
This pattern is different to the one exhibited by the BrUTP
incorporated in the zygote (Fig. 2B). Thus, our results suggest that
histone H3.3 accumulates in the male pronucleus before the
onset of transcription activation.
We performed another series of experiments to confirm our
Fig. 1. Western blot confirming specificity
of the H3.3 antibody (A) and immunochem-
istry revealing presence of Histone H3.3 in
the germinal vesicle stage oocyte (B). (A) 2
micrograms of calf thymus core histones
(CH; 500 ng each of histones H2A, H2B, H3
and H4) and 1 microgram of bacterially puri-
fied and produced histone H3.2 (rH3) were
resolved by SDS-PAGE, Western blotted to
nitrocellulose and probed with the anti-H3.3
antibody. Antibody probing was performed in
the absence or presence of competitor block-
ing peptide (1 µg/ml) as indicated above each
lane on the panel. (B) Single confocal sec-
tions of a germinal vesicle stage (GV) oocyte
and a zygote at the PN0 stage (Adenot et al.,
1997) stained with the H3.3 antibody (green)
and TOTO-3 (DNA, blue). In the oocyte, H3.3
localises mainly to the germinal vesicle with some accumulation in the cytoplasm. After fertilization, before the extrusion of the second polar body
during anaphase of the second meiotic division, H3.3 is dispersed in the cytoplasm. The head of the sperm (blue) is visible on the right hand side
of the zygote. Merge images (top) and grayscale micrographs for H3.3 (bottom) are shown. Scale bar represents 40 µm.
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results. We injected mRNA for HA-tagged H3.3 into zygotes at the
fertilisation cone stage, that is, right after fertilisation and before
pronuclear formation. We then analysed the distribution of H3.3-
HA at similar pronuclear stages as above. The results shown in
Figure 3A demonstrate that the tagged version of H3.3 recapitu-
lates the distribution pattern of the endogenous H3.3. Namely, we
first observe a clear enrichment of H3.3-HA in the male pro-
nucleus at early pronuclear stages whereas H3.3-HA is undetect-
able in the female pronucleus at the same stages. We first detect
H3.3-HA in the female pronucleus at the PN3-PN4 stages, but the
accumulation of H3.3-HA is still higher in the male pronucleus
(Fig. 3A-C). At the PN5 stage the distribution of H3.3-HA is
equivalent in the two pronuclei (Fig. 3A). Thus, these experiments
confirm our observations using the H3.3 specific antibody. These
Fig. 2. Deposition of histone H3.3 in the zygote occurs first in the male pronucleus
around the PN2 stage before the onset of transcription activation. (A) Embryos were
collected at the indicated hours after hCG injection (h phCG) and processed for immunof-
luorescence for H3.3 (green). DNA is shown in blue in the merge panel (top). Classification
of the pronuclear (PN) stages was done according to Adenot et al., (1997). For the control
panel, a PN5 zygote for which only the secondary antibody was used is shown and the
embryos were processed using the same confocal parameters. Shown are single confocal
sections of representative embryos in which the maximum diameter of both pronuclei are on the same confocal plane. The male pronucleus is indicated
with an arrow. Scale bar represents 40 µm.  (B) Transcription activation is first detected in the zygote around the PN5 stage. Early zygotes were
microinjected with BrUTP and cultured until the PN3-PN4 (~24 h phCG) or the PN5 (~27h phCG) stages, when they were fixed and processed for
immunofluorescence using an anti-BrdU antibody (green). A non-injected embryo cultured until the PN5 stage is shown as negative control (-BrUTP).
DNA is in blue in the top panel. Shown are single confocal micrographies of representative pronuclei at the indicated times after hCG injection. The
pronucleus shown in all cases is the male and similar results were obtained for the female pronucleus. (C) Higher magnifications of representative
pronuclei at the indicated zygote stages and of a 2-cell stage nucleus showing punctate localization of H3.3. Shown are merged single confocal sections
where H3.3 is shown in green and DNA in blue.
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results also suggest that the preferential incorpora-
tion in the male pronucleus is inherent to H3.3,
regardless of whether it is the endogenous protein
or a tagged injected one. This indicates that there
is no obvious requirement for pre-existing covalent
modified H3.3 for its appropriate deposition.
The female pronucleus is enriched in mono and
trimethylated H3K4, defining an epigenetic asym-
metry between the two pronuclei, which disappears
at the PN5 stage (Lepikhov and Walter, 2004)(Fig.
3C). To unequivocally distinguish between the male
and female pronucleus, we performed double
immunostaining for H3.3-HA and H3K4me3 from
PN3 through PN5 stages. These experiments con-
firmed that the male pronucleus is enriched in H3.3-
HA (Fig. 3C). We also analysed the distribution of
H3K4me2 from PN3 through PN5. We find that the
levels of H3K4me2 are much higher in the female
pronucleus, but in contrast to H3K4me3, they re-
main asymmetric throughout all the pronuclear
stages analysed (Fig. 3B). Unexpectedly thus, the
female pronucleus is enriched in H3K4 mono, di
and trimethylation, which are ‘active’ marks, whilst
H3.3 is enriched in the male pronucleus. Moreover,
we find that at the PN2 stage, when H3.3 is clearly
restricted to the male pronucleus, H3K4me2 is not
detected in the paternal chromatin and the levels of
H3K4me3 are low (Fig. 4). This data suggests that
in the mouse embryo, H3.3 is hypomethylated at K4
and that H3.3 may progressively become methy-
lated as the first cell cycle progresses.
We then analysed the expression of histone
H3.3 in 4-cell stage embryos and in the blastocyst.
The histone H3.3 is readily detected in the four
nuclei of the 4-cell stage embryos and the fluores-
cent signal is much stronger than in 2-cell stage
embryos (Fig. 5A). H3.3 exhibits a widespread
nuclear distribution with some accumulation in a
few dots in the nucleoplasm and is absent from the
densely DNA-stained heterochromatic regions and
from around the nucleolar-like bodies (Fig. 5B).
Thus, its localization is predominantly euchromatic
at the 4-cell stage. In the blastocyst, H3.3 is also
Fig. 3. HA tagged H3.3 is incorporated first in the
male pronucleus and the female pronucleus reaches
equivalent levels only at the PN5 stage. (A) Distribu-
tion of HA-tagged H3.3 in the mouse zygote at different
pronuclear stages. Zygotes were microinjected at the
fertilisation cone stage with HA.H3.3 mRNA, cultured to
the indicated pronuclear stages, fixed and processed for
immunofluorescence using an anti HA antibody (green).
(B,C) Embryos were processed as in (A) but they were
also stained with an antibody specific for dimethyl- (B) or
trimethyl (C) H3K4 (red in the merge panel). The female
pronucleus is distinguishable due to the enrichment in
methylated H3K4. In all panels DNA is shown in blue in
the merge composites (top). Shown are stack Z-series
projections of representative embryos. Scale bar repre-
sents 50 µm. The male pronucleus is indicated with an
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widely expressed in the nuclei of all cells. We do not detect any
obvious difference in the H3.3 content between the inner cell mass
and the trophectoderm (Fig. 5A). Analysis of blastocyst cells under
higher magnification revealed that H3.3 was widespread in the
nucleoplasm but accumulated within two foci of much greater
intensity in each nucleus of both the inner cell mass (not shown)
and the trophectoderm (Fig. 5C). Thus, in the blastocyst, the
pattern of nuclear distribution of histone H3.3 is also different
compared to the one in the 4-cell stage embryo.
Discussion
The mouse embryo undergoes reprogramming of its epigenetic
marks during the first cell cycles (Li, 2002, Morgan et al., 2005). The
epigenetic status of each cell within the embryo will be determined
not only by differences in DNA methylation and histone modifica-
tions, but also by the content of histone and histone variants. Here
we have shown that the histone H3 variant, H3.3, is deposited
specifically in the male pronucleus. Moreover, there seems to be
a dicotomy since the male pronucleus does not have active
methylation marks in K4 of histone H3 at the early stages of
pronuclear formation.
The zygote gradually acquires a permissive state for transcrip-
tion (Latham et al., 1992). Thus, the alterations in chromatin
structure that follow fertilisation could contribute to rendering the
zygote transcriptionally competent. The observed incorporation of
H3.3, which has been reported to be enriched at active genes and
to contain active marks (McKittrick et al., 2004, Schwartz and
Ahmad, 2005), could contribute to the acquisition of this state.
Asymmetries in the epigenetic status of the parental genomes
occur in the zygote. These include active DNA demethylation in the
paternal genome but not in the maternal one and accumulation of
H3K4me1, H3K9me2 and H3K27me3 in the female pronucleus
(Arney et al., 2002, Lepikhov and Walter, 2004, Santos et al.,
2005). In contrast, the male pronucleus displays higher levels of
histone H4 acetylation than the maternal chromatin (Adenot et al.,
1997). However, histone H4 acetylation and methylation of H3K4
reach similar levels in both pronuclei at the end of the zygote stage
and the main differences between them remain in heterochromatic
structures and imprinting (Santos et al., 2005). Here we show,
consistent with the differences in histone modifications, that there
is also an asymmetry in the incorporation of H3.3 into the pronuclei.
This asymmetry disappears at the late zygote stage. Our results
are in line with recent work by van der Heijden and colleagues, who
reported enrichment of H3.1 in the female pronucleus but not in the
male one, leading the authors to suggest that the male pronucleus
would be enriched in H3.3 (van der Heijden et al., 2005). Changes
in the histone composition in the male pronucleus may be neces-
sary for the first wave of transcriptional activation that starts first in
the paternal genome, which supports higher levels of transcription
than the maternal pronucleus (Aoki et al., 1997, Bouniol et al.,
1995, Bouniol-Baly et al., 1997). Additionally, the differential incor-
poration of H3.3 into the pronuclei may also contribute to ‘delay’ the
incorporation of repressive marks into the paternal genome (Arney
et al., 2002, Lepikhov and Walter, 2004, Santos et al., 2005).
We observed changes in the pattern of nuclear distribution of
histone H3.3. A characteristic punctate pattern found at the 2-cell
stage changes into a more widely dispersed at the 4-cell stage. In
the blastocyst, we observed a characteristic enrichment in two
spots in the nucleoplasm. It is interesting to note that these
changes correlate with the three major changes in transcript profile
in the embryo: the first one up to the 2-cell stage, the second one
after the 4-cell stage and the third one that leads to cellular
differentiation in the blastocyst (Hamatani et al., 2004, Wang et al.,
2004).
Deposition of histone H3.3 in somatic cells can occur in both
replication-dependent or independent mechanisms (Ahmad and
Henikoff, 2002a, Ahmad and Henikoff, 2002b). Histones are first
detected in the male pronucleus at the early PN1 stage (Adenot et
al., 1997, Arney et al., 2002, Lepikhov and Walter, 2004). We
observed incorporation of H3.3 in the male pronucleus around the
PN2 stage, before the onset of transcription activation, suggesting
that the deposition of H3.3 in the zygote may not (at least initially)
be coupled to genome activation. Indeed, HIRA, which is known to
mediate H3.3 deposition in somatic cells (Tagami et al., 2004) was
recently reported to be present in the sperm nucleus during
decondensation immediately after fertilization and before genome
activation (van der Heijden et al., 2005). Given that replication in
the zygote starts at ~21h phCG and that BrdU incorporation is not
detected in PN1 and PN2 embryos (Adenot et al., 1997, Bouniol-
Baly et al., 1997), it is possible that H3.3 incorporation is also
independent of DNA synthesis. Morever, the punctate localization
pattern that we observed for H3.3 in the zygote persists until the
late 2-cell stage when two rounds of replication have already
occurred. So it is conceivable that the incorporation of H3.3 in the
zygote occurs by a different mechanism independent of replication
and transcription. A recent report has indeed documented that in
Drosophila, HIRA is required for removal of the protamines
(Jayaramaiah Raja and Renkawitz-Pohl, 2005) and for chromatin
assembly in the male pronucleus (Loppin et al., 2005). Moreover,
maternal H3.3-Flag specifically accumulates in the male pro-
nucleus, suggestive of a replication independent nucleosome
assembly at the genome wide level.
Fig. 4. The distribution of di- and trimethylated H3K4 at the earlier
pronuclear stages is assymetric. Zygotes were collected at the PN2
stage, fixed and stained with specific methyl antibodies as indicated (red).
DNA is shown in blue. Shown are stack Z-series projections of representa-
tive embryos. The male pronucleus is depicted by an arrow. Scale bar
represents 50 µm. Note that the levels of H3K4me3 in the male pronucleus
are low but detectable, whereas those of H3K4me2 are undetectable.
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 Genetic ablation of some of the histone modifiers that are
involved in the establishment of epigenetic asymmetries in the
zygote such as Enhancer of Zeste 2 results in impaired develop-
ment (Erhardt et al., 2003, Santos et al., 2002). A hypomorphic
mutation of the H3f3a gene, coding for H3.3, results in male sub-
fertility (Couldrey et al., 1999). Thus, it will be interesting to
determine whether H3.3 has a role in the reprogramming of the
parental genomes that follow fertilisation. Investigating not only the
changes in chromatin modifications but also histone composition
during this period, will help to understand the mechanisms under-
lying these events. Our results, which analyse the distribution of
histone H3.3 throughout preimplantation development make a
contribution towards this goal.
Experimental Procedures
Embryo collection and culture
Embryos were collected from F1 (C57BL/6 x CBA/H) ~6 weeks old
superovulated females that were crossed with F1 males as described
(Hogan et al., 1994). Zygotes and cleavage stage embryos were collected
at the indicated hours post-hCG (h phCG). Oocytes were recovered from
~6 weeks old F1 females as described by Hogan et al (Hogan et al., 1994).
Experiments with animals were carried out according to the Home Office
regulation. Pronuclear stages (PN) were classified according to Adenot et
al (1997; TableI and Fig. 3 therein, according to both, post-hCG time and
the distance between pronuclei) and corresponded approximately to the
following times after hCG injection in our strain and Animal Facility: PN0-
PN1, 18h phCG; PN2, 20h phCG; PN3-PN4, 24h phCG; PN5, 27h phCG.
For the BrUTP experiments, we refer to the hCG timing throughout the text
so that the experimental design is clearer to understand.
Immunostaining and confocal analysis
After removal of the zona pellucida with acid Tyrode’s solution (Sigma),
embryos were washed three times in PBS and fixed in 5% paraformalde-
hyde, 0.04% Triton, 0.3% Tween and 0.2% sucrose in PBS for 20 minutes
at 37°C. After permeabilisation with 0.5% Triton in PBS for 20 minutes, the
embryos were washed three times in PBS-T (0.1% Tween in PBS), blocked
in 3% BSA in PBS-T and incubated with the primary antibodies (H3.3
ab4263, abcam, 1:75 dilution; anti histone H3 dimethyl K4 ab7766, abcam,
1:150 dilution; anti histone H3 trimethyl K4 ab8580, 1:150 dilution; anti HA
antibody clone 3F10, Roche, 1:500 dilution) for ~12 h at 4°C. It is essential
to note that we used an early batch of the H3.3 antibody, which was affinity
purified from the first serum. This batch was fully characterized (Fig. 1A)
and was shown to recognise nucleosomal histone H3.3 in vivo in ChIP
assays by two independent laboratories (Johnson et al., 2004; Daujat, S.
personnal communication). Embryos were then washed twice in PBS-T,
blocked for 30 minutes and incubated for 2 h at 25°C with the corresponding
secondary antibodies (FITC-conjugated donkey anti rabbit IgG, Jackson
ImmunoResearch). After 2 washes in PBS-T, the DNA was stained with
TOTO-3 (Molecular Probes) and the embryos were mounted in Vectashield
(Vector Laboratories). Confocal microscopy was performed using a 40x oil
objective in a BioRad 1024 inverted microscope (Blastocysts) or a 60x oil
objective in a BioRad Radiance Upright Confocal Laser Microscope using
the BioRad LaserSharp 2000 software (all the other stages). All the
stainings were repeated independently at least two times with at least 10
embryos analysed per stage.
BrUTP labelling
BrUTP labelling was performed as described (Borsuk and Maleszewski,
2002)(Torres-Padilla and Zernicka-Goetz, submitted). Embryos were
collected at 20h phCG and microinjected using an Eppendorf Transjector
5246 with 1-2 pl of 100 mM BrUTP (5-bromo UTP, Sigma) in 2mM PIPES,
140mM KCl, pH 7.4. Embryos were fixed after culture at the time
equivalent to 24 and 27h phCG and processed for immunostaining using
an anti-BrdU antibody (1:100 dilution, Sigma).
mRNA microinjection
Zygotes were collected at the fertilisation cone stage (~17h phCG) and
microinjected with 1-2 pl of 500 ng/µl of C-terminal double HA-tagged
(human) histone H3.3 mRNA capped and transcribed in vitro. Zygotes
were then cultured in KSOM under a %5 CO2 atmosphere at 37°C, fixed
at the different pronuclear stages as indicated in the figure legends and
Fig. 5. Distribution of H3.3 in mouse 4-cell stage embryos and blastocyst. (A) Embryos were collected from the oviduct, processed for
immunofluorescence with the H3.3 antibody and analysed under confocal microscopy. H3.3 is shown in green, DNA in blue. Shown are stack, single
channel and merge confocal sections of representative embryos at the indicated stages. Scale bar represents 10 µm. (B) Higher magnification of one
of the nuclei of the 4-cell stage embryo shown in (A). Note that H3.3 is distributed throughout the nucleoplasm but is absent from the densely stained
heterochromatic regions. Shown are single confocal sections from single channel acquisitions and the corresponding merge image. Scale bar
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processed for immunofluorescence. At least 20 embryos per stage from
two independent experiments were analysed.
Western blot
Two micrograms of core histone preparation (500 ng of each, SIGMA)
or 1 µg of purified bacterially produced histone H3.2 were resolved by
SDS-PAGE, blotted to nitrocellulose and probed O.N. with the anti H3.3
antibody (1:1000 dilution). Competitor peptides were added as indicated
at a concentration of 1 µg/ml. The H3.3 antibody used (ab4263, Batch
34119) was obtained from Abcam Ltd., UK. It was thoroughly characterised
with regards to its specificity. Due to production issues, it is no longer
commercially available.
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